PureTech Health plc

OTCPK:PRTC.Y Stock Report

Market Cap: US$387.0m

PureTech Health Management

Management criteria checks 3/4

PureTech Health's CEO is Rob Lyne, appointed in Jul 2025, has a tenure of less than a year. total yearly compensation is $732.78K, comprised of 3.7% salary and 96.3% bonuses, including company stock and options. directly owns 0.047% of the company’s shares, worth $182.22K. The average tenure of the management team and the board of directors is 2.5 years and 5.1 years respectively.

Key information

Rob Lyne

Chief executive officer

US$732.8k

Total compensation

CEO salary percentage3.67%
CEO tenure1yr
CEO ownership0.05%
Management average tenure2.5yrs
Board average tenure5.1yrs

Recent management updates

Recent updates

Seeking Alpha • Mar 23

PureTech Health: Repeat What Works

Summary PureTech Health's founded entity, Karuna Therapeutics, has been successful in developing a therapeutic with an optimized profile. Karuna Therapeutics was acquired by BMY for $14 billion. PureTech's lead asset, LYT-100, may be a promising treatment for idiopathic pulmonary fibrosis (IPF) with a better tolerability profile compared to standard of care drugs. Read the full article on Seeking Alpha
Seeking Alpha • Oct 06

PureTech Health jumps 9.3% on takeover speculation

PureTech Health (NASDAQ:PRTC) soared 9.3% on some speculation that the company may be a takeover target. People following the matter have heard some speculation that PureTech (PRTC) received some takeover interest, according to a Betaville item. Developing story ...
Seeking Alpha • Aug 25

PureTech GAAP EPS of -$0.10, revenue of $7.03M

PureTech press release (NASDAQ:PRTC): 1H GAAP EPS of -$0.10. Revenue of $7.03M (+20.4% Y/Y). Strong capital base with PureTech Level Cash and Cash Equivalents of $341.4M and Consolidated Cash and Cash Equivalents of $365.9M as of June 30, 2022, excluding up to $115.4 million added post-period ; Operational runway extended into Q1 2026.

CEO Compensation Analysis

How has Rob Lyne's remuneration changed compared to PureTech Health's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025US$733kUS$27k

-US$110m

Compensation vs Market: Rob's total compensation ($USD732.78K) is below average for companies of similar size in the US market ($USD2.47M).

Compensation vs Earnings: Insufficient data to compare Rob's compensation with company performance.

CEO

Rob Lyne (43 yo)

1yr
Tenure
US$732,776
Compensation

Mr. Robert Lyne, LLB, JD, also known as Rob, was Non-Employee Director of Seaport Therapeutics, Inc. from March 2026. He is Chief Executive Officer and Director at PureTech Health plc since December 18, 20...

Leadership Team

NamePositionTenureCompensationOwnership
Robert Lyne
CEO & Director1yrUS$732.78k0.047%
$ 182.2k
Robert S. Langer
Co-Founder & Non-Executive Directorno dataUS$270.00k1.35%
$ 5.2m
Eric Elenko
Co-Founder & President2.3yrsno datano data
David Elmaleh
Co-Founder & Senior Advisorno datano datano data
Lauren White
Chief Financial Officer1.7yrsno datano data
Charles Sherwood
COO, General Counsel & Company Secretary2.5yrsno datano data
Michael Inbar
Chief Accounting Officer1.3yrsno datano data
Allison Talbot
Senior VP of Communications & Head of Investor Relationsno datano datano data
Spencer Ball
Executive Vice President of Human Resources6yrsno datano data
Aleksandra Filipovic
Head of Oncology6yrsno datano data
Anita Terpstra
Senior Vice President of Intellectual Property6yrsno datano data
Joy Bauer
Chief Nutrition Officer4.6yrsno datano data
2.5yrs
Average Tenure
53yo
Average Age

Experienced Management: PRTC.Y's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Robert Lyne
CEO & Directorless than a yearUS$732.78k0.047%
$ 182.2k
Robert S. Langer
Co-Founder & Non-Executive Directorno dataUS$270.00k1.35%
$ 5.2m
David Elmaleh
Co-Founder & Senior Advisorno datano datano data
H. Horvitz
Board Observer10.7yrsno datano data
John LaMattina
Senior Independent Director17.5yrsUS$290.00k0.62%
$ 2.4m
Sharon Mates
Directorless than a yearno datano data
Dennis Ausiello
Board Advisor10.7yrsno datano data
Kiran Mazumdar-Shaw
Independent Non-Executive Director5.8yrsUS$235.00k0.045%
$ 173.4k
Michele A. Holcomb
Independent Non-Executive Director1.8yrsUS$255.00k0.033%
$ 126.0k
Sharon Barber-Lui
Independent Interim Chair4.3yrsUS$284.03k0.067%
$ 259.3k
5.1yrs
Average Tenure
73yo
Average Age

Experienced Board: PRTC.Y's board of directors are considered experienced (5.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 09:43
End of Day Share Price 2026/07/07 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PureTech Health plc is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jens LindqvistInvestec Bank plc (UK)
Peter WelfordJefferies LLC
Miles DixonPeel Hunt LLP